A novel tubular construct using silk fibroin-chitosan scaffold seeded with bone marrow mesenchymal stem cells for urinary diversion in a preclinical rabbit model - Scorecard - MDSpire

A novel tubular construct using silk fibroin-chitosan scaffold seeded with bone marrow mesenchymal stem cells for urinary diversion in a preclinical rabbit model

  • By

  • Qianliang Wang

  • Qingling Liu

  • June 23, 2026

  • 0 min

Share

Clinical Scorecard: Development of a Silk Fibroin-Chitosan Scaffold-Based Tubular Graft Inoculated with Bone Marrow Mesenchymal Stem Cells for Urinary Diversion in a Preclinical Rabbit Study

At a Glance

CategoryDetail
ConditionUrinary Diversion
Key MechanismsUse of bone marrow mesenchymal stem cells (BMSCs) and silk fibroin/chitosan (SF/CS) scaffolds for tissue-engineered tubular grafts (TETGs).
Target PopulationPreclinical rabbit model.
Care SettingTissue engineering and regenerative medicine.

Key Highlights

  • remove

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Clinical Best Practices

          • remove

          Related Resources & Content

            Original Source(s)

            A novel tubular construct using silk fibroin-chitosan scaffold seeded with bone marrow mesenchymal stem cells for urinary diversion in a preclinical rabbit model

            • by Qianliang Wang, Qingling Liu

            • June 23, 2026

            Related Content

            Innovative technique to cover exposed dura mater after occipital osteomyelitis, using our triple layer using matriderm. A case report

            Sex-specific echocardiographic remodeling and prognostic value of left ventricular sphericity, pressure–dimension index, and myocardial work after durable LVAD implantation

            Permanent pacemaker rate following Commando and Hemi-Commando procedures: a systematic review and meta-analysis